Europe (WHO region) vs Kazakhstan: Confirmed cases of MDR-TB
Europe (WHO region)
36,772
in 2012
Kazakhstan
7,608
in 2012
Europe (WHO region) rank
2nd
Kazakhstan rank
4th
Confirmed cases of MDR-TB over time
- Europe (WHO region)
- Kazakhstan
How they compare
Europe (WHO region) currently reports 36,772 against 7,608 in Kazakhstan, a difference of 29,164.
That makes Europe (WHO region)'s figure about 4.8 times Kazakhstan's.
Across all 7 years both countries report, Europe (WHO region) has been ahead every year.
Europe (WHO region) ranks 2nd and Kazakhstan ranks 4th of 11 groups.
Europe (WHO region) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17,175 | 4,251 | 12,924 | Europe (WHO region) |
| 2010s | 34,916 | 7,468 | 27,448 | Europe (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb, Europe (WHO region) or Kazakhstan?
- Europe (WHO region), at 36,772 against 7,608 in Kazakhstan as of 2012.
- What is the difference in confirmed cases of mdr-tb between Europe (WHO region) and Kazakhstan?
- 29,164, with Europe (WHO region) ahead.
- How many years of comparable data are there for Europe (WHO region) and Kazakhstan?
- 7 years are reported by both, from 2006 to 2012.
- How do Europe (WHO region) and Kazakhstan rank globally for confirmed cases of mdr-tb?
- Europe (WHO region) ranks 2nd and Kazakhstan ranks 4th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB. Statizoid refreshes it automatically from the source and publishes the full history for both places.